IL1B and cystic fibrosis: Recently, Balazs et al. [77] suggested a role for the IL-1 signaling pathway in the pathogenesis of sterile neutrophilic inflammation and mucus hypersecretion in CF, and highlighted the potential role of Anakinra, an IL-1 antagonist, as an anti-inflammatory treatment in CF.